INTRODUCTION
The elevated uric acid level (hyperuricemia) occur in 5% of the general population and most of them are asymptomatic.
1
Since 1963, allopurinol has been introduced and widely using to reduce the uric acid level.
2 In vivo, allopurinol converts into oxypurinol which serves as xanthine analog and combine with xanthine oxydase enzyme, which intern prevents the formation of uric acid in the body.
3 Although, allopurinol is generally well tolerated, life-threatening toxic effects have been reported from different regions. 1, 2, 4, 5 Erythroderma alternatively termed as generalized exfoliative dermatitis is one of the adverse reactions triggered by allopurinol.
Erythroderma is a scaly, erythematous dermatitis that involves at least 90% of the surface of the skin. It is a rare disease, and its occurrence might be closely linked to:
